Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

TMK reported for 9 months of 2024 by RAS

10/22/24 TRMK

Softline has entered the market of Uzbekistan

10/22/24 SOFL

Diasoft reported for 9 months of 2024 by RAS

10/22/24 DIAS

Magnit opened the first Magnet Go in the Moscow subway

10/22/24 MGNT

Yandex.Fabrika presented its first brand of basic clothing

10/22/24 YDEX

T-Investments will launch trading in digital financial assets

10/22/24 TCSG

NKHP reported for 9 months of 2024 by RAS

10/22/24 NKHP

Izhstal reported for 9 months of 2024 by RAS

10/22/24 IGST

Seligdar reduced gold production by 5%

10/22/24 SELG

TGC-1 increased energy generation by 9%

10/22/24 TGKA